Influenza virus-like particle production in plants
AssigneeAramis Biotechnologies Inc.
InventorsManon Couture, Marc-Andre D'Aoust, Louis-Philippe Vezina
Life of this patent
Estimating the term…
Loading patent…
AssigneeAramis Biotechnologies Inc.
InventorsManon Couture, Marc-Andre D'Aoust, Louis-Philippe Vezina
Estimating the term…
A method of producing a virus like particle (VLP) in a plant comprising modified H3 hemagglutinin is provided. The method comprises introducing a nucleic acid comprising a regulatory region active in the plant and operatively linked to a nucleotide sequence encoding a modified influenza hemagglutinin (HA) protein into the plant, or portion of the plant, the modified HA protein comprises a modified proteolytic loop. Followed by incubating the plant or portion of the plant under conditions that permit the expression of the nucleic acids, thereby producing the VLP. The modified proteolytic loop may comprise one or more protease cleavage sites exhibiting reduced or abolished cleavage by a protease. Also described is a virus like particle (VLP) produced by the method, and plants expressing the VLP. The virus like particle (VLP) may comprise plant-specific N-glycans, or modified N-glycans.
A modified influenza type A subtype H3 hemagglutinin (HA) comprising a fully deleted proteolytic loop between subunits HA1 and HA2.
A composition comprising a virus like particle (VLP) comprising a modified influenza type A subtype H3 hemagglutinin (HA) comprising a fully deleted proteolytic loop between subunits HA1 and HA2.
A plant comprising a modified influenza type A subtype H3 hemagglutinin (HA) comprising a fully deleted proteolytic loop between subunits HA1 and HA2.
A plant comprising a virus like particle (VLP) comprising a modified influenza type A subtype H3 hemagglutinin (HA) comprising a fully deleted proteolytic loop between subunits HA1 and HA2.
Dependencies are inferred from the claim text.